ArticleNeuro-oncology2022
Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade glioma.
Tom Rosenberg et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
40 papers cite it
this paperpooled ittrialcites it